Description: Chairperson's column for the May 2023 issue of NewsDirect discussing the Section's strategic themes for the year.

Description: There are a variety of regulatory changes that are being contemplated by the National Association of Insurance Commissioners (NAIC) that have the potential to materially impact actuarial, statutory reporting and disclosure requirements relating to reinsurance. This session will provide an introduction to these changes, explaining both the motivation as well as the potential impact these proposed changes may have on US ceding companies. The focus of the presentation will be primarily on changes affecting Asset Adequacy Testing and statutory risk transfer for combination Coinsurance / Yearly Renewable Term agreements. An update will be provided regarding industry responses to proposed changes and the potential timing for implementation of these new requirements.

Description: This session will review reinsurance fundamentals, risk assessment techniques, optimization strategies, and regulatory considerations through case studies and best practices. Attendees will gain insights into enhancing capital management, risk mitigation, and improving operating results, utilizing practical insights from both reinsurers and direct experience.

Description: The session will start by looking at emerging trends in US population mortality improvement focusing especially on recent deviations from the traditional norms influenced by factors such as the prescription drug epidemic, aging populations, improvements in medical technology and socioeconomic differentiation. Explore the recently developed SOA Research Institute tool looking at US life insured mortality experience to see to what extent insights from the population view are present in insured mortality and how to make the best use of the tool. The session will conclude with observations on key points to keep in mind in your own understanding of mortality improvement development as well as engage the audience to gather your perspective.

Description: Many companies are facing challenges with their inforce UL business. These “distressed” or non-core blocks of business can be a drag on earnings, return on capital, and/or internal resources. With the pressures of today's marketplace, companies are seeking efficient strategies for managing these blocks. The good news is that strategies exist such that inforce UL business can be optimized with some attention. Learn about some options and levers companies have available to help manage these blocks.

Description: The article summarizes the results of the 2024 Life Reinsurance Survey of Individual Life and Group Life business written in the traditional life reinsurance markets of the United States and Canada. The article summarizes the new business volume written in 2024 and 2023 as well as the volume of ceded reinsurance in force at year-end 2024 and 2023.

Description: What are insurance companies promoting in the market? How are they framing their products and services? What is their value proposition to producers? Members of the SOA Marketing and Distribution section receive an exclusive benefit that addresses these questions.

Description: The Canadian Institute of Actuaries (CIA) and Society of Actuaries (SOA) engaged RGA Reinsurance Company (RGA) to undertake a research project on level premium term life insurance products with a particular focus on the magnitude and impact of the “shock lapse” at the end of the level premium period. This project is similar to the SOA-sponsored research completed by RGA in 2014 for USA business.

Description: How do socioeconomic factors influence mortality outcomes—and what does this mean for actuaries? Join the Society of Actuaries for a 75-minute webcast presenting new research on U.S. mortality patterns by Socioeconomic Index Score (SIS). This study extends lifetable and cause-specific mortality analysis through 2023, capturing the impact of the COVID-19 pandemic and documenting variations across socioeconomic categories.

Description: Modifiable risk factors stand out today as significant contributors to diseases, and yet we as an industry haven't tackled this. Instead, we sit by almost passively as obesity, diabetes and hypertension rates continue to skyrocket. In fact, obesity and overweight is now over 70% of the US population and has turned into the forgotten pandemic. Globally, no country in the world has improved their obesity percentage rates during the past 15 years. Insurers are starting to explore health interventions which have the potential to reduce claims and change people's behavior.